Tirzepatide getting a dual GLP-one and GIP agonist, it can be suggested that the GIP ingredient of twin agonism may very well be responsible for the extra gain, given the probable benefit of GIP receptor agonism on peripheral insulin sensitization. Therefore, tirzepatide was more effective than dulaglutide in lessening fasting dietary TAG [six,7].